Clinic News

Latest in Cardiology

ACC Statement Opposes Legislative Mandates For Universal ECG Screening in Competitive Athletes
Legislative mandates for universal electrocardiogram (ECG) screening in competitive athletes pose potential harm and unintended consequences, drawing attention and resources away from emergency action plan (EAP) implementation, an effective intervention for saving athletes' lives...
Healthy Versions of Low-Carb and Low-Fat Diets Linked to Better CV and Metabolic Health
The quality of a low-carbohydrate or low-fat diet may matter more than the amount of carbohydrates or fat consumed when it comes to reducing heart disease risk, according to a study published Feb. 11 in JACC. Researchers found that versions of both diet patterns emphasizing macronutrients from healthy foods were associated with a lower risk […]
BASEL-PMI: Does Cardiologist Evaluation in Patients With PMI Reduce CV Risk?
One year after major noncardiac surgery, patients who received an evaluation for perioperative myocardial infarction/injury (PMI) by a cardiologist had a lower risk of all-cause mortality and major cardiac events, according to a multicenter prospective study published Jan. 30 in EHJ. The findings suggest that interdisciplinary management may improve postoperative outcomes in patients with PMI.
COACT 5 Year Data: Similar Survival With Immediate vs. Delayed Coronary Angiography in OHCA Survivors
At five years, survival was comparable between immediate and delayed angiography with no clinical benefit or harm in patients without ST-segment elevation resuscitated from out-of-hospital cardiac arrest (OHCA), according to new results from the randomized COACT trial published Feb. 4 in JACC.
Substantial Hospital-Level Variation in Immediate Coronary Angiography Among Patients With STEMI and OHCA | NCDR Study
Among patients presenting with both out-of-hospital cardiac arrest (OHCA) and STEMI, substantial hospital-level variation was found in providing immediate coronary angiography (CA), according to a Brief Report published Feb. 11 in JACC.
ACCEL Lite: VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or Stroke
In this interview, Nanette Kass Wenger MD, MACC and Erin A. Bohula, MD, FACC discuss the VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or Stroke.
CORALreef Lipids: Oral PCSK9 Inhibitor Enlicitide Reduces LDL-C in High-Risk Patients
Enlicitide decanoate, an oral PCSK9 inhibitor, significantly reduced LDL-C levels in patients with a history of or at risk for a first atherosclerotic cardiovascular disease (ASCVD) event, according to results of the CORALreef Lipids trial published Feb. 4 in the NEJM.
To Î² or Not to Î²? Insights From the BETAMI-DANBLOCK Trial
The BETAMI-DANBLOCK (Beta-Blockers after Myocardial Infarction in Patients without Heart Failure) trial results demonstrated that, in patients with recent type 1 or type 2 myocardial infarction (MI) and left ventricular ejection fraction (LVEF) â‰¥40%...
Noninvasive Predictors of LA Compliance Post TMVT
In patients with severe mitral regurgitation (MR), low left atrial (LA) reservoir strain (LASr) and prior atrial fibrillation (AFib) intervention or LA appendage (LAA) ligation may predict low invasive LA compliance and limited V-wave reduction after transcatheter mitral valve therapy (TMVT)...
EMPHASIS: Minocycline Initiation Effective, Safe Within 72 Hours of Acute Ischemic Stroke
Initiation of the multi-target anti-neuroinflammatory drug minocycline within 72 hours of acute ischemic stroke had a significant benefit in functional outcome compared to placebo, with no increased safety risks, according to findings from the EMPHASIS trial published Jan. 30 in The Lancet.